The Opioid Crisis: At the Intersection of Human Health and Veterinary Medicine
Between 1999 and 2017, almost 500,000 people died from an opioid overdose, both prescription and illicit. In 2014, it was reported that there were approximately 150% more opioid overdose deaths than deaths from motor vehicle crashes. On average, we are now seeing 50,000 opioid deaths per year. Approximately 40% of these deaths involve a prescription opioid, not illicit drugs. We are losing more than 140 Americans per day to overdoses and millions more are struggling with opioid addiction. In 2017, Health and Human Services declared a public health emergency and announced a 5-Point Strategy to combat this crisis.
The human opioid crisis has clearly impacted veterinary medicine including drug shortages and the need for alternative methods to address pain, drug seeking pet owners, and opioid abuse among team members. In addition to providing humane care for animal patients, veterinarians have a role to play in combatting the abuse and misuse of pain medications.
Here are the burning questions we’ll address:
What is the history of the opioid crisis and how does it affect veterinarians’ prescribing ability?
How is the human medical world approaching this problem?
Is that a concerned pet owner or a drug seeker with a fishy story?
Am I following DEA regulations appropriately?
As a veterinarian, how do I report opioid prescriptions?
Should we treat chronic pain with opioid drugs?
When is the goal of reducing pain for veterinary patients causing too many other medical problems?
Are there alternatives to opioid drugs?
Learn how veterinary medicine can be a part of the solution to this devastating crisis and how veterinary medicine can best address the ramifications of a national epidemic.
Brad Finegood, Seattle King County Public Health
Brad Finegood is a Strategic Advisor in Public Health Seattle – King County. He recently served as a co-chair of the King County Heroin and Prescription Opiate Task Force and was the Alcohol and Drug Coordinator for King County. He received his Bachelor’s Degree from Michigan State University and his Master’s Degree in Community Agency Counseling with a Specialty in Alcohol and Drug Abuse from Western Michigan University. He has worked in the behavioral health field for 20 years and has provided direct service in multiple modalities including prevention, outpatient, residential and Medication Assisted Treatment, both in institutions and the community. Most importantly he is the sibling and survivor of a younger sibling that passed away of an overdose.
Ricardo Quintero, DEA
Ricardo Quintero is a Diversion Program Manager with the Drug Enforcement Administration assigned to the Seattle, Washington Field Division. In 1999, Mr. Quintero began his career as a Diversion Investigator with DEA in Denver, Colorado. In 2013, Mr. Quintero transferred to the Seattle Field Division as the Diversion Group Supervisor, and subsequently promoted to the Diversion Program Manager (DPM) Position. Prior to working with DEA, Mr. Quintero was with the U.S. Border Patrol in the southwest border area of New Mexico and Texas.
Gary Garrety, WA State Dept of Health Prescription Monitoring Program
Gary Garrety is the Operations Manager for the Prescription Monitoring Program at the Washington State Department of Health. In his ten years of government service for the state of Washington he’s worked to support health professionals struggling with substance misuse issues often into recovery. Mr. Garrety’s studies focused on Engineering and Mathematics while at Louisiana State University; and on Organizational Development at The Evergreen State College (2007). Gary has overseen operations for the Washington State Department of Health’s Prescription Monitoring Program since 2014. He currently serves executive roles for two national committees focused on interstate standards based PMP data exchange.
Tamara Grubb, DVM, PhD, DACVA
Dr. Tamara Grubb is a board certified veterinary anesthesiologist with a strong clinical interest and research focus in pain management. She is an anesthesia/analgesia consultant in both small and large animal practices, a certified acupuncturist, a member of the International Academy of Veterinary Pain Management, a RACE-approved CE provider and an Adjunct Professor of Veterinary Anesthesia & Analgesia at Washington State University. Dr. Grubb’s favorite achievement is winning the Carl J. Norden Distinguished Teaching Award, which has been awarded to her from students at two universities.
Lucinda Grande, MD
Dr. Grande is a family physician with a special interest in chronic pain and addiction. She incorporates sublingual ketamine, buprenorphine, and traditional opioids among her tools for managing chronic pain in her primary care practice, and served on the advisory committee for the 2015 Washington State AMDG Opioid Guidelines update. She prescribes buprenorphine for opioid use disorder, advocates for access to medications for addiction treatment in jails and hospitals at the state and national level, and led development of the recently opened low-barrier Olympia Bupe Clinic. Dr. Grande’s medical degree is from the University of Washington School of Medicine.
Lisa Parshley, DVM, PhD, DACVIM
Dr. Parshley currently works at and co-owns the Olympia Veterinary Cancer Center. Dr. Parshley earned a PhD in biochemistry from Oregon Health Sciences University and completed a post-doctoral fellowship at University of Washington. In 2003, she received a DVM from Colorado State University and one year later completed a small animal internship at Cornell University. She completed a medical oncology residency at Michigan State University and has become a diplomate of the American College of Veterinary Internal Medicine (oncology). Dr. Parshley also has extensive experience in emergency medicine, critical care, and palliative medicine.
Pricing & Discounts